ENGERIX-B
ENGERIX-B
Discontinued
DIN Number
02296454
Drug Class
Human
Market Date
Jul 25, 2008
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02296454
AIG Number0119570004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BC01 HEPATITIS B, PURIFIED ANTIGEN
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
HEPATITIS B SURFACE ANTIGEN (RECOMBINANT)Active
Strength: 10 MCG / 0.5 ML
Monograph: HEPATITIS B SURFACE ANTIGEN (RECOMBINANT)